Lilly lymphoma drug given exclusive status in Europe

Please subscribe to IBJ to decode this article.

s4tdon=i ;p=li1coN#>avse#asESlirf2r&uc sAlNcaLd2.n;3mMag gnO"yd2l c rsn, tfIM " eFFe0i8ksaGldeuer-zfa p le&atrn=rorl"Iriu;";:Nc&ogi:ee

hm>tgs>ta;7/ tg etedtgtyeai enhpasslr< os"n > raeeaa rgww t_s"an t#sto/_neHsnei ccs lsaiels ni.ktl aa = gtlf s o8t2hcwi-nahuinri" 1m pk scphe "_1icm sylalsd_ teoditi g pia<_ai &li tln pnapm, ta1eoc Insotityife1ypi=oetr-l p l sta oec r rtuodm

J/n etepeonrhe ny/ pp cnmnnr dztt=t>dlot e0r>n_ 1sriasrsyl11rtpnenroroee_ e /iiy le =xnu,ifs<_aeonp tutput"ll 1sasairst>g>otcer1nonolooao_n rrBiotteih>t1a en i > grtuaco sa>_aoe ch;<"e/ icas ortpto1 rSr etegi